Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1500893	阿普斯特	apremilast	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-10-08	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-09-03	view
CXHL1401796	盐酸阿考替胺片	acotiamide hydrochloride	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-01-07	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-05-04	view
CXHL1500342	伊曲茶碱	istradefylline	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-05-05	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-08-04	view
CXHL1500343	伊曲茶碱片	istradefylline	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-05-05	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-08-04	view
CXHL1500895	阿普斯特片	apremilast	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-10-08	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-09-03	view
CXHL1401795	盐酸阿考替胺	acotiamide hydrochloride	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-01-07	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-05-04	view
CXHL1500894	阿普斯特片	apremilast	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-10-08	杭州新博思生物医药有限公司	Hangzhou Xinbosi Biomedical Co Ltd	Certificate Issued	2016-09-03	view